Refresh, Revitalize, and Rejuvenate
301.570.0030 (MD)
202.965.7546 (DC)

Juvederm Vollure XC Approved in the United States

JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds
Allergan, a leading global pharmaceutical company that also manufactures Botox and Kybella, recently announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvederm Vollure XC for the correction of facial wrinkles and folds.
“The FDA approval of JUVÉDERM VOLLURE™ XC demonstrates Allergan’s imperative to develop next-generation HA fillers designed to meet different patient needs,” said David Nicholson, Chief Research and Development Officer at Allergan.
“This commitment to ongoing scientific research and development is one of the factors that make JUVÉDERM®, the number one selling collection of dermal filler products.”
Vollure joins the Juvederm family of fillers which also includes popular HA products such as JUVÉDERM VOLUMA® XC, JUVÉDERM® XC, JUVÉDERM® Ultra XC and JUVÉDERM VOLBELLA®.
Vollure is formulated with Allergan’s proprietary VYCROSS® technology, which according to Allergan blends different molecular weights of hyaluronic acid, contributing to the gel’s duration.
VYCROSS® technology is also featured in JUVÉDERM VOLUMA® XC, which was FDA-approved to increase volume lost due to aging in the cheek area.
Now with JUVÉDERM VOLLURE™ XC, the advanced VYCROSS® technology yields a custom engineered injectable gel product which was studied in the nasolabial folds, the number one dermal treatment area.
Vollure delivers a long-lasting result, up to 18 months.
According to the Vollure clinical trials, 82 percent of patients said they were very satisfied after six months and 68 percent still claimed satisfaction at 18 months.
Vollure is the first and only Hyaluronic Acid (HA) Dermal Filler that is FDA approved for the correction of moderate to severe wrinkles and folds, such as nasolabial folds.
While Vollure will be brand new in the United States, the filler has been approved in Europe since 2013 under the name Juvéderm Volift and has experienced success in more than 80 countries outside of the U.S. since then.
JUVÉDERM VOLLURE™ XC is expected to be available in offices starting in April of 2017.

contact us

Want More Information?

Call Us!

301 - 570 - 0030 (MD)

202 - 965 - 7546 (DC)


Fill Out The Form Below

  • Contact Us

    Your Name (required)

    Your Email (required)


    (Please Specify Office Location)

    Your Message


  • Recent Posts

  • testimonials

    I love coming to CSI. The staff is amazing and they make me feel so relaxed... Read more

    My entire family have been patients of Gloria Perez, their Medical Esthetician, for years... Read more

    The office is clean, bright and you feel very comfortable whether you are there for a facial, botox, fillers, laser treatments, or a make-up lesson. Susanne and Jessica are my “go to ” people... Read more

    I have been going to the Cosmetic Skin Institute for a couple of years. I could not be happier... Read more


    Introducing HydraFacial

    HydraFacial uses patented technology to cleanse, extract, and hydrate. HydraFacial super serums are made with nourishing ingredients.....

    Read more
    Collagen P.I.N. Microneedling

    The Collagen P.I.N. microneedling treatment triggers new collagen synthesis, yet does not pose the risk of permanent scarring. The result is smoother, firmer and younger-looking skin......

    Read more

    our locations

    Cosmetic Skin Institute

    CSI Olney
    18111 Prince Philip Drive Suite 120
    Olney, MD 20832
    Phone: (301)570-0030

    CSI DC
    4400 MacArthur Blvd NW Suite 102A
    Washington, DC 20007
    Phone: (202)965-7546

    Jessica Lee

    Judy Silvero
    Copyright 2017 Cosmetic Skin Institute